Keeping Track: Janssen Gets A Breakthrough Therapy Status, FDA Awards Two Orphan Drug Designations, Portola Lands A CRL

 
• By Michael Cipriano

The latest drug development news and highlights from our FDA Performance Tracker.

More from Product Reviews

More from Pink Sheet